Tenormin is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Direct_rx. The primary component is Atenolol.
Product ID | 72189-396_ee143f2f-be61-bc67-e053-2a95a90ae6e6 |
NDC | 72189-396 |
Product Type | Human Prescription Drug |
Proprietary Name | Tenormin |
Generic Name | Atenolol |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2022-11-22 |
Marketing Category | ANDA / |
Application Number | ANDA077443 |
Labeler Name | Direct_Rx |
Substance Name | ATENOLOL |
Active Ingredient Strength | 25 mg/1 |
Pharm Classes | Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-11-22 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
52427-431 | TENORMIN | TENORMIN |
52427-430 | TENORMIN | TENORMIN |
52427-429 | TENORMIN | TENORMIN |
0093-0752 | Atenolol | Atenolol |
0093-0753 | Atenolol | Atenolol |
0093-0787 | Atenolol | Atenolol |
0378-0218 | Atenolol | atenolol |
0378-0231 | Atenolol | atenolol |
0378-0757 | Atenolol | atenolol |
0615-3532 | Atenolol | atenolol |
0615-3533 | Atenolol | atenolol |
0615-3544 | Atenolol | Atenolol |
0615-8026 | Atenolol | Atenolol |
0615-8027 | Atenolol | Atenolol |
0615-8372 | Atenolol | Atenolol |
0615-8373 | Atenolol | Atenolol |
0781-1078 | Atenolol | Atenolol |
0781-1506 | Atenolol | Atenolol |
0781-1507 | Atenolol | Atenolol |
0781-5220 | Atenolol | Atenolol |
0781-5225 | Atenolol | Atenolol |
0781-5229 | Atenolol | Atenolol |
0904-5392 | Atenolol | Atenolol |
0904-7187 | Atenolol | Atenolol |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TENORMIN 77957605 3964271 Live/Registered |
ALVOGEN IP CO S.A.R.L. 2010-03-12 |
TENORMIN 77826093 not registered Dead/Abandoned |
Fera Pharmaceuticals, LLC 2009-09-14 |
TENORMIN 73080253 1065132 Dead/Expired |
IMPERIAL CHEMICAL INDUSTRIES LIMITED 1976-03-15 |